» Articles » PMID: 30511897

Pulmonary Vein Ganglia Are Remodeled in the Diabetic Heart

Overview
Date 2018 Dec 5
PMID 30511897
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background Cardiac autonomic neuropathy is thought to cause adverse cardiovascular effects in diabetes mellitus. Pulmonary vein ganglia ( PVG ), which have been implicated in normal and abnormal heart rhythm regulation, have not been fully investigated in type 1 diabetes mellitus (T1D). We examined the functional and anatomical effects of T1D on PVG and studied the details of T1D-induced remodeling on the PVG structure and function. Methods and Results We used a mouse model of T1D (Akita mouse), immunofluorescence, isolated Langendorff-perfused hearts, and mathematical simulations to explore the effects of T1D on PVG . Whole-mount atrial immunofluorescence of choline acetyltransferase and tyrosine hydroxylase labeling showed that sympathetic and parasympathetic somas of the PVG neurons were significantly hypotrophied in T1D hearts versus wild type. Stimulation of PVG in isolated Langendorff-perfused hearts caused more pronounced P-P interval prolongation in wild type compared with Akita hearts. Propranolol resulted in a comparable P-P prolongation in both phenotypes, and atropine led to more pronounced P-P interval shortening in wild type compared with Akita hearts. Numerical modeling using network simulations revealed that a decrease in the sympathetic and parasympathetic activities of PVG in T1D could explain the experimental results. Conclusions T1D leads to PVG remodeling with hypotrophy of sympathetic and parasympathetic cell bodies and a concomitant decrease in the PVG sympathetic and parasympathetic activities.

Citing Articles

The Intrinsic Cardiac Nervous System: From Pathophysiology to Therapeutic Implications.

Giannino G, Braia V, Griffith Brookles C, Giacobbe F, DAscenzo F, Angelini F Biology (Basel). 2024; 13(2).

PMID: 38392323 PMC: 10887082. DOI: 10.3390/biology13020105.


Neonatal Scn1b-null mice have sinoatrial node dysfunction, altered atrial structure, and atrial fibrillation.

Ramos-Mondragon R, Edokobi N, Hodges S, Wang S, Bouza A, Canugovi C JCI Insight. 2022; 7(10).

PMID: 35603785 PMC: 9220823. DOI: 10.1172/jci.insight.152050.


Increased arrhythmia susceptibility in type 2 diabetic mice related to dysregulation of ventricular sympathetic innervation.

Jungen C, Scherschel K, Flenner F, Jee H, Rajendran P, De Jong K Am J Physiol Heart Circ Physiol. 2019; 317(6):H1328-H1341.

PMID: 31625779 PMC: 6962614. DOI: 10.1152/ajpheart.00249.2019.


Pulmonary Vein Ganglia Are Remodeled in the Diabetic Heart.

Bassil G, Chang M, Pauza A, Diaz Vera J, Tsalatsanis A, Lindsey B J Am Heart Assoc. 2018; 7(23):e008919.

PMID: 30511897 PMC: 6405566. DOI: 10.1161/JAHA.118.008919.

References
1.
Movahed M, Hashemzadeh M, Jamal M . Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol. 2005; 105(3):315-8. DOI: 10.1016/j.ijcard.2005.02.050. View

2.
Armour J . Potential clinical relevance of the 'little brain' on the mammalian heart. Exp Physiol. 2007; 93(2):165-76. DOI: 10.1113/expphysiol.2007.041178. View

3.
Choi E, Zhao Y, Everett 4th T, Chen P . Ganglionated plexi as neuromodulation targets for atrial fibrillation. J Cardiovasc Electrophysiol. 2017; 28(12):1485-1491. PMC: 5722676. DOI: 10.1111/jce.13319. View

4.
Goudis C, Korantzopoulos P, Ntalas I, Kallergis E, Liu T, Ketikoglou D . Diabetes mellitus and atrial fibrillation: Pathophysiological mechanisms and potential upstream therapies. Int J Cardiol. 2015; 184:617-622. DOI: 10.1016/j.ijcard.2015.03.052. View

5.
Tsujimura T, Nunotani H, Fushimi H, Inoue T . Morphological changes in autonomic ganglionic cells of the heart in diabetic patients. Diabetes Res Clin Pract. 1986; 2(3):133-7. DOI: 10.1016/s0168-8227(86)80014-6. View